Vericel Corp Ord Stock Buy Hold or Sell Recommendation

VCEL Stock  USD 45.38  1.64  3.75%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Vericel Corp Ord is 'Strong Hold'. Macroaxis provides Vericel Corp buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding VCEL positions. The advice algorithm takes into account all of Vericel Corp's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Vericel Corp's buy or sell advice are summarized below:
Real Value
43.83
Target Price
41.08
Hype Value
45.4
Market Value
45.38
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Vericel Corp Ord given historical horizon and risk tolerance towards Vericel Corp. When Macroaxis issues a 'buy' or 'sell' recommendation for Vericel Corp Ord, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Vericel Corp Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as Vericel and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Vericel Corp Ord. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

Execute Vericel Corp Buy or Sell Advice

The Vericel recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Vericel Corp Ord. Macroaxis does not own or have any residual interests in Vericel Corp Ord or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Vericel Corp's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Vericel CorpBuy Vericel Corp
Strong Hold

Market Performance

ModestDetails

Volatility

Very steadyDetails

Hype Condition

Low keyDetails

Current Valuation

Fairly ValuedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Actively responds to the marketDetails

Investor Sentiment

ImpartialDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

PoorDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Vericel Corp Ord has a Risk Adjusted Performance of 0.0721, Jensen Alpha of 0.0991, Total Risk Alpha of (0.05), Sortino Ratio of 0.0729 and Treynor Ratio of 0.1296
Vericel Corp Ord recommendation module can be used to check and cross-verify current trade recommendation provided by analysts inspecting the firm's potential to grow using all of fundamental, technical, data market data available at the time. To make sure Vericel Corp Ord is not overpriced, please validate all Vericel Corp fundamentals, including its book value per share, total asset, and the relationship between the cash per share and target price . Given that Vericel Corp Ord has a number of shares shorted of 4.39 M, we advise you to double-check Vericel Corp Ord market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your current risk tolerance and investing horizon.

Vericel Corp Trading Alerts and Improvement Suggestions

The company reported the previous year's revenue of 197.52 M. Net Loss for the year was (3.18 M) with profit before overhead, payroll, taxes, and interest of 109.79 M.
Vericel Corp Ord has a poor financial position based on the latest SEC disclosures
Over 99.0% of the company outstanding shares are owned by institutional investors
Latest headline from investing.com: Vericel CEO sells over 1.5m in company stock

Vericel Corp Returns Distribution Density

The distribution of Vericel Corp's historical returns is an attempt to chart the uncertainty of Vericel Corp's future price movements. The chart of the probability distribution of Vericel Corp daily returns describes the distribution of returns around its average expected value. We use Vericel Corp Ord price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Vericel Corp returns is essential to provide solid investment advice for Vericel Corp.
Mean Return
0.25
Value At Risk
-3.1
Potential Upside
4.36
Standard Deviation
2.33
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Vericel Corp historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Vericel Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Vericel Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vericel Corp Ord backward and forwards among themselves. Vericel Corp's institutional investor refers to the entity that pools money to purchase Vericel Corp's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Geode Capital Management, Llc2023-12-31
M
Goldman Sachs Group Inc2023-12-31
944.4 K
Bnp Paribas Investment Partners Sa2023-12-31
920.9 K
William Blair Investment Management, Llc2023-12-31
834.9 K
Dimensional Fund Advisors, Inc.2023-12-31
730.4 K
Jpmorgan Chase & Co2023-12-31
691.6 K
Ameriprise Financial Inc2023-12-31
675.2 K
Point72 Asset Management, L.p.2023-09-30
617.6 K
Nuveen Asset Management, Llc2023-12-31
606.9 K
Blackrock Inc2023-12-31
7.9 M
Brown Capital Management, Llc2023-12-31
6.8 M
Note, although Vericel Corp's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Vericel Corp Cash Flow Accounts

201920202021202220232024 (projected)
Change In Cash8.7M6.9M34.7M(17.5M)35.8M37.6M
Free Cash Flow(9.8M)14.9M21.1M10.1M7.8M8.2M
Depreciation1.7M2.4M3.0M4.0M4.6M4.9M
Other Non Cash Items2.8M4.4M4.4M3.7M(369K)(350.6K)
Capital Expenditures2.6M2.6M7.9M7.6M27.5M28.9M
Net Income(9.7M)2.9M(7.5M)(16.7M)(3.2M)(3.3M)
End Period Cash Flow27.0M33.8M68.5M51.1M86.9M91.2M
Change To Inventory(3.3M)(2.5M)(4.0M)(2.6M)2.9M3.0M
Change Receivables(8.7M)(2.3M)(2.9M)(9.1M)(8.2M)(7.8M)
Change To Netincome13.2M13.9M34.3M37.2M42.8M44.9M
Investments13.2M(14.5M)4.4M(36.2M)(16.8M)(17.6M)

Vericel Corp Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Vericel Corp or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Vericel Corp's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Vericel stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
0.1
β
Beta against NYSE Composite1.83
σ
Overall volatility
2.25
Ir
Information ratio 0.07

Vericel Corp Volatility Alert

Vericel Corp Ord currently demonstrates below-average downside deviation. It has Information Ratio of 0.07 and Jensen Alpha of 0.1. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Vericel Corp's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Vericel Corp's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Vericel Corp Fundamentals Vs Peers

Comparing Vericel Corp's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Vericel Corp's direct or indirect competition across all of the common fundamentals between Vericel Corp and the related equities. This way, we can detect undervalued stocks with similar characteristics as Vericel Corp or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Vericel Corp's fundamental indicators could also be used in its relative valuation, which is a method of valuing Vericel Corp by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Vericel Corp to competition
FundamentalsVericel CorpPeer Average
Return On Equity-0.0152-0.31
Return On Asset-0.0129-0.14
Profit Margin(0.02) %(1.27) %
Operating Margin0.20 %(5.51) %
Current Valuation2.09 B16.62 B
Shares Outstanding48.38 M571.82 M
Shares Owned By Insiders0.84 %10.09 %
Shares Owned By Institutions99.16 %39.21 %
Number Of Shares Shorted4.39 M4.71 M
Price To Earning357.33 X28.72 X
Price To Book10.26 X9.51 X
Price To Sales11.73 X11.42 X
Revenue197.52 M9.43 B
Gross Profit109.79 M27.38 B
EBITDA(1.83 M)3.9 B
Net Income(3.18 M)570.98 M
Cash And Equivalents100.69 M2.7 B
Cash Per Share2.13 X5.01 X
Total Debt88.14 M5.32 B
Debt To Equity0.28 %48.70 %
Current Ratio6.20 X2.16 X
Book Value Per Share4.72 X1.93 K
Cash Flow From Operations35.31 M971.22 M
Short Ratio8.38 X4.00 X
Earnings Per Share(0.07) X3.12 X
Target Price53.9
Number Of Employees31418.84 K
Beta1.73-0.15
Market Capitalization2.12 B19.03 B
Total Asset353.66 M29.47 B
Retained Earnings(403.18 M)9.33 B
Working Capital159.88 M1.48 B
Current Asset21.1 M9.34 B
Note: Disposition of 17500 shares by Dominick Colangelo of Vericel Corp at 44.59 subject to Rule 16b-3 [view details]

Vericel Corp Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Vericel . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Vericel Corp Buy or Sell Advice

When is the right time to buy or sell Vericel Corp Ord? Buying financial instruments such as Vericel Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2021 2022 2023 2024 (projected)
Short and Long Term Debt Total50.1M47.6M88.1M92.6M
Total Assets243.7M273.0M353.7M371.3M

Use Investing Ideas to Build Portfolios

In addition to having Vericel Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Warren Buffett Holdings Thematic Idea Now

Warren Buffett Holdings
Warren Buffett Holdings Theme
A long-term portfolio of publicly-traded stocks on US exchanges that are owned by Warren Buffett's holding company Berkshire Hathaway. The Warren Buffett Holdings theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Warren Buffett Holdings Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:
Check out Vericel Corp Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
Note that the Vericel Corp Ord information on this page should be used as a complementary analysis to other Vericel Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Vericel Stock analysis

When running Vericel Corp's price analysis, check to measure Vericel Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vericel Corp is operating at the current time. Most of Vericel Corp's value examination focuses on studying past and present price action to predict the probability of Vericel Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vericel Corp's price. Additionally, you may evaluate how the addition of Vericel Corp to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Is Vericel Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.045
Earnings Share
(0.07)
Revenue Per Share
4.15
Quarterly Revenue Growth
0.233
Return On Assets
(0.01)
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.